Revenue decreased 14.0%
Revenue changed -14.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed -14.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stockholders' equity changed -7.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -8.6% from the comparable as-filed period.
Total assets changed -0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Net income changed -17.8% from the comparable as-filed period.
Shares outstanding changed -8.6% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Revenue changed -11.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stockholders' equity changed +2.7% from the comparable as-filed period.
Total assets changed +2.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.